Gut · 2017 · 75 citations · 25 references
MedicineOncologySurgeryGastrointestinal OncologyMicrosurgerySurgical OncologyColorectal CancerColorectal SurgeryEndoscopic SurgeryEndoscopic Tumor ResectionGastrointestinal Cancer SurgeryTumor Resection TechniquesClinical Outcome MeasurementColorectal AdenomasCost-effectivenessEndoscopic Surgical ResectionRectal Cancer SurgeryRectal ResectionRecurrenceTransanal Resection
OBJECTIVE: Non-randomised studies suggest that endoscopic mucosal resection (EMR) is equally effective in removing large rectal adenomas as transanal endoscopic microsurgery (TEM), but EMR might be more cost-effective and safer. This trial compares the clinical outcome and cost-effectiveness of TEM and EMR for large rectal adenomas. DESIGN: Patients with rectal adenomas ≥3 cm, without malignant features, were randomised (1:1) to EMR or TEM, allowing endoscopic removal of residual adenoma at 3 months. Unexpected malignancies were excluded postrandomisation. Primary outcomes were recurrence within 24 months (aiming to demonstrate non-inferiority of EMR, upper limit 10%) and the number of recurrence-free days alive and out of hospital. RESULTS: Two hundred and four patients were treated in 18 university and community hospitals. Twenty-seven (13%) had unexpected cancer and were excluded from further analysis. Overall recurrence rates were 15% after EMR and 11% after TEM; statistical non-inferiority was not reached. The numbers of recurrence-free days alive and out of hospital were similar (EMR 609±209, TEM 652±188, p=0.16). Complications occurred in 18% (EMR) versus 26% (TEM) (p=0.23), with major complications occurring in 1% (EMR) versus 8% (TEM) (p=0.064). Quality-adjusted life years were equal in both groups. EMR was approximately €3000 cheaper and therefore more cost-effective. CONCLUSION: Under the statistical assumptions of this study, non-inferiority of EMR could not be demonstrated. However, EMR may have potential as the primary method of choice due to a tendency of lower complication rates and a better cost-effectiveness ratio. The high rate of unexpected cancers should be dealt with in further studies.
25
Classification of Surgical Complications
Daniel Dindo, Nicolas Demartines, Pierre-Alain Clavien · Annals of Surgery · 2004 · 30.9K citations · Full text
Medicine, Surgery, General Surgery +13
Prevention of Colorectal Cancer by Colonoscopic Polypectomy
Sidney J. Winawer, Ann G. Zauber, May Nah Ho et al. · New England Journal of Medicine · 1993 · 4.6K citations · Full text
Reporting of Noninferiority and Equivalence Randomized Trials
Gilda Piaggio, Diana R Elbourne, Stuart Pocock et al. · JAMA · 2012 · 2.4K citations